About ARISE

While the Southeast Asian region has become a destination spot for clinical trials implemented by developed countries and the COVID-19 pandemic unveiled the poor health emergency preparedness all over the world; researchers and organizations found the need to strengthen their capacities in term of infectious diseases research and preparedness.
It is subsequently imperative to promote health research that would enable a rapid initiation and completion of high-quality trials to accelerate the access to the necessary health products and to be ready for upcoming outbreaks.

Led by Japan through the National Center for Global Health and Medicine, the ARISE was launched in 2021 regrouping institutions from Indonesia, Japan, Malaysia, the Philippines, Thailand and Vietnam.

GOVERNANCE

The ARISE is funded by the Japan Agency for Medical Research and Development (AMED) subsidized project, “Clinical research and clinical trial platform formation to promote international research cooperation between Japan and Asian countries in the field of infectious diseases.

VISION

To be a leading and reliable collaborative network of AROs in Asia that will facilitate and optimize the conduct of infectious diseases clinical trials.

MISSION

GOALS (2024-2025)

1. Promote participation in and conduct of infectious diseases clinical trials in collaboration with industries
2. Ensure the integrity, safety, ethics, and quality of investigator-initiated clinical trials
3. Enhance the resources and capacity for clinical trials implementation

ORGANIZATIONAL STRUCTURE